Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistance and could provide predictive information. Altered expressions of several microRNAs including miR-21-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Future Sci OA
Main Authors: Schlick, Konstantin, Hohla, Florian, Hamacher, Frank, Hackl, Hubert, Hufnagl, Clemens, Markus, Steiner, Magnes, Teresa, Gampenrieder, Simon Peter, Melchardt, Thomas, Stättner, Stefan, Hauser-Kronberger, Cornelia, Greil, Richard, Rinnerthaler, Gabriel
Formato: Artigo
Idioma:Inglês
Publicado em: Future Science Ltd 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://ncbi.nlm.nih.gov/pubmed/33437513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados